Researcher profile

Devika S

Devika S contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 17 - UnverifiedVerification L1Unclaimed author
4works
0followers
5topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

4 published item(s)

preprint2020arXiv

Development of a Machine Learning Model and Mobile Application to Aid in Predicting Dosage of Vitamin K Antagonists Among Indian Patients

Patients who undergo mechanical heart valve replacements or have conditions like Atrial Fibrillation have to take Vitamin K Antagonists (VKA) drugs to prevent coagulation of blood. These drugs have narrow therapeutic range and need to be very closely monitored due to life threatening side effects. The dosage of VKA drug is determined and revised by a physician based on Prothrombin Time - International Normalised Ratio (PT-INR) value obtained through a blood test. Our work aimed at predicting the maintenance dosage of warfarin, the present most widely recommended anticoagulant drug, using the de-identified medical data collected from 109 patients from Kerala. A Support Vector Machine (SVM) Regression model was built to predict the maintenance dosage of warfarin, for patients who have been undergoing treatment from a physician and have reached stable INR values between 2.0 and 4.0.